TY - JOUR
T1 - Dyslipidemia management in patients with human immunodeficiency virus
T2 - A review
AU - Brett-Major, David M.
AU - Ganesan, Anuradha
N1 - Funding Information:
The authors would like to thank the Natural Sciences and Engineering Research Council of Canada for financial support. The authors are grateful to Habibollah Hajhashemi for helpful discussions on how to generate structured meshes for mixing systems.
PY - 2007/1
Y1 - 2007/1
N2 - Both effective antiretroviral therapy and human immunodeficiency virus (HIV) infection have been associated with changes in serum lipids. Data on the relevance of this dyslipidemia on cardiovascular risk are growing. Although guidelines for managing dyslipidemia in HIV-infected patients are available, consideration of the changing literature is important to develop a stepwise approach for management. In this review, the 2003 guidelines of Infectious Diseases Society of America and HIV Medicine Association on dyslipidemia management of patients on antiretroviral therapy are merged with subsequent literature.
AB - Both effective antiretroviral therapy and human immunodeficiency virus (HIV) infection have been associated with changes in serum lipids. Data on the relevance of this dyslipidemia on cardiovascular risk are growing. Although guidelines for managing dyslipidemia in HIV-infected patients are available, consideration of the changing literature is important to develop a stepwise approach for management. In this review, the 2003 guidelines of Infectious Diseases Society of America and HIV Medicine Association on dyslipidemia management of patients on antiretroviral therapy are merged with subsequent literature.
UR - http://www.scopus.com/inward/record.url?scp=33846305437&partnerID=8YFLogxK
U2 - 10.1097/01.idc.0000239720.32336.99
DO - 10.1097/01.idc.0000239720.32336.99
M3 - Review article
AN - SCOPUS:33846305437
SN - 1056-9103
VL - 15
SP - 7
EP - 16
JO - Infectious Diseases in Clinical Practice
JF - Infectious Diseases in Clinical Practice
IS - 1
ER -